Genesee Capital Advisors, LLC Palatin Technologies Inc Transaction History

Genesee Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	BUY	$0.44 - $0.63 $4,620 - $6,615	10,500 New	10,500 $5,000
Q2 2021 Jul 20, 2021	SELL	$0.48 - $0.72 $5,040 - $7,560	-10,500 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$0.98 - $1.64 $10,290 - $17,220	10,500 New	10,500 $12,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.38M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.